WordNet

(medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"
of or belonging to endocrine glands or their secretions; "endocrine system" (同)endocrinal

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ホルモン療法を用いた閉経期症状の治療 treatment of menopausal symptoms with hormone therapy
2. 転移性ホルモン受容体陽性乳癌に対する治療アプローチ：内分泌療法 treatment approach to metastatic hormone receptor positive breast cancer endocrine therapy
3. 閉経期のホルモン療法で用いる製剤 preparations for menopausal hormone therapy
4. 非転移性ホルモン受容体陽性乳癌に対する補助内分泌療法 adjuvant endocrine therapy for non metastatic hormone receptor positive breast cancer
5. 閉経期のホルモン療法：利益とリスク menopausal hormone therapy benefits and risks

Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.

Culig Z1.
Journal of cellular physiology.J Cell Physiol.2016 Feb;231(2):270-4. doi: 10.1002/jcp.25099.
Androgen receptor (AR) is a key factor in regulation of growth and differentiation in normal and malignant prostate. Endocrine therapies for prostate cancer include inhibition of androgen production either by analogs of luteinizing hormone releasing hormone or abiraterone acetate and/or use of anti-
PMID 26201947

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies.

Agrawal A1,2, Robertson JF1, Cheung KL1, Gutteridge E3, Ellis IO3, Nicholson RI4, Gee JM4.
International journal of cancer. Journal international du cancer.Int J Cancer.2016 Jan 1;138(1):146-59. doi: 10.1002/ijc.29682. Epub 2015 Jul 30.
We report the first study of the biological effect of fulvestrant on ER positive clinical breast cancer using sequential biopsies through to progression. Thirty-two locally/systemically advanced breast cancers treated with first-line fulvestrant (250 mg/month) were biopsied at therapy initiation, 6
PMID 26178788

Mitkov M1, Joseph R2, Copland J 3rd3.
Molecular and cellular endocrinology.Mol Cell Endocrinol.2015 Dec 5;417:94-102. doi: 10.1016/j.mce.2015.09.020. Epub 2015 Sep 28.
Disparities in the prognosis and incidence of melanoma between male and female patients have led clinicians to explore the influence of steroid hormones on the development and progression of this malignancy. A better understanding of the disparities of melanoma behavior between sexes and ages could
PMID 26415591

Ki-67 Expression for Predicting Progression of Postoperative Residual Pituitary Adenomas : Correlations With Clinical Variables

MATSUYAMA Junko
Neurologia medico-chirurgica = 神経外科 52(8), 563-569, 2012-08-15
… The World Health Organization classification of tumors of endocrine organs defines atypical pituitary adenomas as tumor with Ki-67 labeling index higher than 3%, excessive p53 immunoreactivity, and increased pleomorphism. … A threshold of 2% for the MIB-1 labeling index predicts higher risk of progression of residual adenomas after surgery, so shorter interval of follow-up neuroimaging, and early initiation of adjuvant therapy might be required. …
NAID 10030694615

長嶋隆夫,新納摩子,平山きふ [他],伊達成基,沖原宏治,向所賢一
泌尿器科紀要 58(8), 457-460, 2012-08-00
… We report a case of squamous differentiated prostate carcinoma that developed after combination endocrine therapy for adenocarcinoma of the prostate. … Six weeks after combination endocrine therapy using goserelin acetate and bicalutamide, the patient underwent radical prostatectomy and bilateral pelvic lymphadenectomy. …
NAID 40019388041